180 related articles for article (PubMed ID: 35439759)
21. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
[TBL] [Abstract][Full Text] [Related]
22. Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study.
Serna-Higuita LM; Harrison SL; Buttner P; Glasby M; Raasch BA; Iftner A; Garbe C; Martus P; Iftner T
Acta Derm Venereol; 2019 Apr; 99(4):404-411. PubMed ID: 30547181
[TBL] [Abstract][Full Text] [Related]
23. Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients.
Kim Y; Wojciechowski D; Pattanayak V; Lee H; Asgari MM
J Invest Dermatol; 2020 May; 140(5):995-1002. PubMed ID: 31669059
[TBL] [Abstract][Full Text] [Related]
24. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
25. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.
Lanz J; Bouwes Bavinck JN; Westhuis M; Quint KD; Harwood CA; Nasir S; Van-de-Velde V; Proby CM; Ferrándiz C; Genders RE; Del Marmol V; Forchetti G; Hafner J; Vital DG; Hofbauer GFL
JAMA Dermatol; 2019 Jan; 155(1):66-71. PubMed ID: 30516812
[TBL] [Abstract][Full Text] [Related]
26. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
27. Anatomic Locations of Procedurally Treated Keratinocyte Carcinomas in the US Medicare Population.
Navsaria LJ; Li Y; Tripathy S; Cox ML; Hinkston CL; Margolis DJ; Wehner MR
JAMA Dermatol; 2023 Jun; 159(6):643-647. PubMed ID: 37074701
[TBL] [Abstract][Full Text] [Related]
28. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
29. Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk.
Olsen CM; Pandeya N; Green AC; Ragaini BS; Venn AJ; Whiteman DC
Public Health Res Pract; 2022 Mar; 32(1):. PubMed ID: 35290995
[TBL] [Abstract][Full Text] [Related]
30. Basal cell carcinoma in a 17 year-old organ transplant recipient.
Borges-Costa J
Pediatr Dermatol; 2018 Sep; 35(5):e312. PubMed ID: 29962023
[TBL] [Abstract][Full Text] [Related]
31. Myocardial metastasis of cutaneous squamous cell carcinoma in a renal transplant recipient.
Mackenzie KA; Simcock JW; Lainchbury JG; Currie MJ; Lynn KL
Transplant Proc; 2009 Dec; 41(10):4414-5. PubMed ID: 20005411
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.
Ferreira FR; Ogawa MM; Nascimento LF; Tomimori J
An Bras Dermatol; 2014; 89(5):745-50. PubMed ID: 25184913
[TBL] [Abstract][Full Text] [Related]
33. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
[TBL] [Abstract][Full Text] [Related]
34. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
[TBL] [Abstract][Full Text] [Related]
35. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
36. Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre.
Ge L; Chee SN; Robledo KP; Lowe P
Australas J Dermatol; 2018 Nov; 59(4):291-296. PubMed ID: 29292515
[TBL] [Abstract][Full Text] [Related]
37. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
38. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
[TBL] [Abstract][Full Text] [Related]
39. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
40. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation.
Euvrard S; Kanitakis J; Pouteil-Noble C; Dureau G; Touraine JL; Faure M; Claudy A; Thivolet J
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):222-9. PubMed ID: 7622649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
